3D Bioprinted Muscle and Tendon Tissues for Drug Development

biotechnet Switzerland

Authors

  • Markus Rimann Institute of Chemistry and Biological Chemistry (ICBC), Zurich University of Applied Sciences (ZHAW), Waedenswil, Switzerland
  • Sandra Laternser Institute of Chemistry and Biological Chemistry (ICBC), Zurich University of Applied Sciences (ZHAW), Waedenswil, Switzerland
  • Hansjörg Keller Musculoskeletal Diseases, Novartis Institutes for BioMedical Research, Basel, Switzerland
  • Olivier Leupin Musculoskeletal Diseases, Novartis Institutes for BioMedical Research, Basel, Switzerland
  • Ursula Graf-Hausner Institute of Chemistry and Biological Chemistry (ICBC), Zurich University of Applied Sciences (ZHAW), Waedenswil, Switzerland. guru@zhaw.ch

DOI:

https://doi.org/10.2533/chimia.2015.65

Keywords:

Alternative test method, Bioprinting standardization, 3d cell culture, Drug development, Muscle-tendon disease, Specialized well plate
CHIMIA Vol. 69 No. 1-2 (2015): Chemistry and Light

Downloads

Published

2015-02-25

How to Cite

[1]
M. Rimann, S. Laternser, H. Keller, O. Leupin, U. Graf-Hausner, Chimia 2015, 69, 65, DOI: 10.2533/chimia.2015.65.

Issue

Vol. 69 No. 1-2 (2015): Chemistry and Light

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2015 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.